Alshenawy suggests that no single marker is completely sensitive and specific for the diagnosis of thyroid lesions, but only their combination [ 48 ] and Gal-3 + HBME-1 is considered highly significant for distinguishing benign from malignant lesions [ 49 ].
1
—
—